A mutation causes a defect in the production of exosomes, which has been shown to drive the progression of Alzheimer's ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

With CDMOs playing such a prominent role in biomanufacturing, GEN asked several CDMO leaders for their take on the top trends in the industry, the main challenges facing CDMOs today, and the most ...

GEN spotlights some of the remarkable women who are breaking barriers, setting standards, and driving innovation in this space.

The method offers a scalable way to scour unculturable bacteria for new drug leads and help illuminate a previously hidden microbial world.

Results reported in a preprint connect localized signals in the brain to aging-related changes in immune cells in mouse ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

Phage tail piracy is a cross-species gene-transfer path that spreads AMR and creates new targets for antimicrobial therapies.

Discovering ways to regulate the BNST brain center may lead to new therapies for weight control and chemotherapy side effects.

An immunotherapy drug candidate safely prevents cancer cells from hiding from the immune system’s first responders.

Cytiva demonstrates that manufacturers must expand their focus to include strategic liquid planning for scale-up.